95. Eur J Med Chem. 2018 Jul 17;156:711-721. doi: 10.1016/j.ejmech.2018.07.037. [Epubahead of print]Targeting the MDM2-p53 protein-protein interaction with prenylchalcones:Synthesis of a small library and evaluation of potential antitumor activity.Brandão P(1), Loureiro JB(2), Carvalho S(1), Hamadou MH(2), Cravo S(3), MoreiraJ(1), Pereira D(1), Palmeira A(3), Pinto M(3), Saraiva L(4), Cidade H(5).Author information: (1)Laboratório de Química Orgânica e Farmacêutica, Departamento de CiênciasQuímicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge ViterboFerreira 228, 4050-313, Porto, Portugal.(2)LAQV/REQUIMTE, Laboratório de Microbiologia, Departamento de CiênciasBiológicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge ViterboFerreira 228, 4050-313, Porto, Portugal.(3)Laboratório de Química Orgânica e Farmacêutica, Departamento de CiênciasQuímicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge ViterboFerreira 228, 4050-313, Porto, Portugal; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR), Universidade do Porto, Terminal de Cruzeiros doPorto de Leixões, Av. General Norton de Matos s/nm, 4450-208, Matosinhos,Portugal.(4)LAQV/REQUIMTE, Laboratório de Microbiologia, Departamento de CiênciasBiológicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge ViterboFerreira 228, 4050-313, Porto, Portugal. Electronic address:lucilia.saraiva@ff.up.pt.(5)Laboratório de Química Orgânica e Farmacêutica, Departamento de CiênciasQuímicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge ViterboFerreira 228, 4050-313, Porto, Portugal; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR), Universidade do Porto, Terminal de Cruzeiros doPorto de Leixões, Av. General Norton de Matos s/nm, 4450-208, Matosinhos,Portugal. Electronic address: hcidade@ff.up.pt.Prenylation of several bioactive scaffolds is a very interesting strategy used inMedicinal Chemistry in order to improve biological/pharmacological effects. Asmall library of prenylchalcones was synthesized and evaluated for the ability toinhibit the MDM2-p53 interaction using a yeast-based assay. The capacity of allsynthesized prenylchalcones and their non-prenylated precursors to inhibit thegrowth of human colon tumor HCT116 cells was also evaluated. The obtained resultsled to the identification of a hit compound, prenylchalcone 2e, which behaved as potential inhibitor of the MDM2-p53 interaction in yeast, and showed improvedcytotoxicity against human tumor cells expressing wild-type p53, including liver hepatocellular carcinoma HepG2, breast adenocarcinoma MCF-7, and malignantmelanoma A375 cells. In colon cancer cells, it was also shown that the growthinhibitory effect of prenylchalcone 2e was associated with the induction of cell cycle arrest, apoptosis, and increased protein expression levels of p53transcriptional targets. Moreover, computational docking studies were performedin order to predict docking poses and residues involved in the MDM2-p53 potentialinteraction.Copyright © 2018 Elsevier Masson SAS. All rights reserved.DOI: 10.1016/j.ejmech.2018.07.037 PMID: 30041135 